arrow
G

Georgios F. Nikolaidis

Centre of Excellence in Evidence Synthesis
H指数:9
被引数:486

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative Efficacy and Safety of Tislelizumab in Second-Line Esophageal Squamous Cell Carcinoma: Systematic Literature Review and Simulated Treatment Comparisons

替雷利珠单抗在二线治疗食管鳞状细胞癌中的疗效和安全性比较:系统文献综述和模拟治疗比较

2025-12-030
OAAI
A broader lens on tuberculosis cost-effectiveness analysis: How patient-incurred costs and post-tuberculosis outcomes reshape estimates in a multi-country study

对结核病成本效益分析的更广泛视角:患者承担的成本和结核后结局如何重塑多国研究中的估计值

2025-09-110
OAAI
Including comparative observational evidence in trial-level surrogate endpoint evaluation: assessing relapse-free survival as a surrogate endpoint for overall survival in patients with acute myeloid leukemia post-transplant

将比较性观察证据纳入试验层面的替代终点评估:评估急性髓系白血病移植后患者中无复发生存期作为总生存期的替代终点

2025-08-160
OAAI